 |
| 18-Apr-13 | Reiterated |
Argus |
Buy |
$80 → $96 |
|
| 15-Apr-13 | Reiterated |
Barclays |
Overweight |
$85 → $95 |
|
| 12-Apr-13 | Reiterated |
Deutsche Bank |
Buy |
$82 → $87 |
|
| 26-Mar-13 | Reiterated |
UBS |
Buy |
$81 → $87 |
|
| 11-Jan-13 | Reiterated |
UBS |
Buy |
$76 → $78 |
|
| 04-Jan-13 | Upgrade |
Deutsche Bank |
Hold → Buy |
$75 → $82 |
|
| 20-Nov-12 | Initiated |
Stifel Nicolaus |
Hold |
|
|
| 18-Jul-12 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$65 → $71 |
|
| 18-Apr-12 | Reiterated |
UBS |
Buy |
$71 → $70 |
|
| 12-Dec-11 | Reiterated |
UBS |
Buy |
$72 → $69 |
|
| 17-Oct-11 | Reiterated |
UBS |
Buy |
$74 → $72 |
|
| 24-Aug-11 | Reiterated |
Morgan Keegan |
Mkt Perform |
$70 → $68 |
|
| 29-Apr-11 | Reiterated |
UBS |
Buy |
$67 → $72 |
|
| 26-Jan-11 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$60 → $58 |
|
| 18-Jan-11 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$62 → $60 |
|
| 14-Jan-11 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$62 → $60 |
|
| 21-Jul-10 | Reiterated |
UBS |
Buy |
$75 → $69 |
|
| 21-Jul-10 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$63 → $62 |
|
| 01-Jul-10 | Downgrade |
Standpoint Research |
Buy → Hold |
|
|
| 15-Jul-09 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$54 → $60 |
|
|
|
| 22-May-13 11:45AM | Hedge Funds Trail S&P 500 by 10 Percentage Points, Goldman Says at Bloomberg |
| 11:42AM | [video] Benefiting From the Rotation To Cyclicals at TheStreet |
| 11:35AM | Medtronic Still Reporting Weak Growth, But A Relatively Rare Bargain at Investopedia |
| 11:00AM | Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow at TheStreet |
| 10:51AM | Early Glance: Pharmaceuticals companies AP |
| 10:51AM | Early Glance: Medical Devices companies AP |
| 10:39AM | Swiss Billionaires Buy Merck Geneva Building for Biotech Campus at Bloomberg |
| 10:00AM | 5 Stocks Going Ex-Dividend Tomorrow: SMG, FMER, AIZ, KEY, JNJ at TheStreet |
| 08:50AM | Allocate Assets to Buy-Rated Dow Stocks TheStreet |
| 06:40AM | Stock Market News for May 22, 2013 Zacks |
| 05:32AM | The Long Case For 3M at Seeking Alpha |
| 21-May-13 08:50PM | Final Glance: Pharmaceuticals companies AP |
| 08:50PM | Final Glance: Medical Devices companies AP |
| 07:44PM | [video] Will the Bulls Keep Running Into 2015? at CNBC |
| 06:30PM | The Surprising Link Between ADHD and Obesity at Motley Fool |
| 05:46PM | Pfizer Stock Checkup for May at Motley Fool |
| 05:41PM | JPMorgan Directors Glance: How shareholders voted AP |
| 03:32PM | J&J, Up 26% YTD, Gets After Image Problems YCharts |
| 03:28PM | JPMorgan Directors Glance: How shareholders voted AP |
| 03:05PM | Roche, Reloaded at Investopedia |
| 02:00PM | Harvards Largest Gift Doubles With Second Wyss Donation at Bloomberg |
| 01:16PM | Midday Glance: Pharmaceuticals companies AP |
| 01:16PM | Midday Glance: Medical Devices companies AP |
| 10:58AM | Jim Cramer: Buy Johnson & Johnson, Buy CarMax, Buy These 3 Stocks at Wall St. Cheat Sheet |
| 10:50AM | JNJ's Simponi Label Expanded Zacks |
| 10:36AM | Early Glance: Pharmaceuticals companies AP |
| 10:36AM | Early Glance: Medical Devices companies AP |
| 09:42AM | Long-Term Biotech: 3 Names To Discover Now at Seeking Alpha |
| 09:27AM | Is There a Pill For That? Forest Labs Iffy Pipeline YCharts |
| 08:59AM | Medtronics Heart Rhythm Devices Show Signs of Growth at Bloomberg |
| 06:13AM | [$$] Dividend Stocks, the New Nifty 50? at Barrons.com |
| 02:06AM | Johnson & Johnson Stock Checkup for May at Motley Fool |
| 02:05AM | Cordis Showcases Cardiovascular Innovations at EuroPCR 2013 Business Wire |
| 20-May-13 08:45PM | The Case for Big Bank Stocks in Your Retirement Account at Motley Fool |
| 06:09PM | 2013's Top 5 Companies for the Ordinary Investor at Motley Fool |
| 06:05PM | Final Glance: Pharmaceuticals companies AP |
| 06:05PM | Final Glance: Medical Devices companies AP |
| 06:00PM | Cramer: How to Invest Like the Ridiculously Rich at CNBC |
| 04:00PM | Column: Two ways to pick your summer stock retreat Reuters |
| 03:50PM | Investing For The Other Half at Motley Fool |
| 03:33PM | Have Defensive Stocks Had Their Day? at Seeking Alpha |
| 03:15PM | Johnson & Johnson's Short-Term Pipeline at Seeking Alpha |
| 02:30PM | 6 Healthy Products That Aren't at Minyanville |
| 02:03PM | How Dividends Change the Game for Johnson & Johnson Stock at Motley Fool |
| 01:17PM | Midday Glance: Pharmaceuticals companies AP |
| 01:17PM | Midday Glance: Medical Devices companies AP |
| 12:01PM | 1 Pioneering Device to Jump-Start the Cardiovascular Industry at Motley Fool |
| 11:48AM | Abbott gets some analyst love for diversifying, meeting generic threats at MarketWatch |
| 10:50AM | Will Obamacare Crush Medtronic's Earnings? at Motley Fool |
| 10:33AM | Early Glance: Pharmaceuticals companies AP |
| 10:33AM | Early Glance: Medical Devices companies AP |
| 10:24AM | 'High Beta' Funds in High Gear: Should You Buy In? at Barrons.com |
| 03:54AM | Johnson & Johnson Dividend Stock Analysis at Seeking Alpha |
| 19-May-13 11:45PM | Consumer group flags high SPF ratings on sunscreen AP |
| 11:25AM | Johnson & Johnson and Merck Lead the Dow Healthcare Stock Rollercoaster Ride This Week at Wall St. Cheat Sheet |
| 07:39AM | Further Analysis Of The 40 Stock Portfolio at Seeking Alpha |
| 18-May-13 03:00PM | This 10-Stock Dividend Strategy Is Trouncing the Dow at Motley Fool |
| 17-May-13 06:34PM | Abbott Laboratories Stock Checkup for May at Motley Fool |
| 06:29PM | [video] Companies That Shine After Spinoffs at CNBC |
| 06:03PM | Final Glance: Medical Devices companies AP |
| 06:03PM | Final Glance: Pharmaceuticals companies AP |
| 02:13PM | J&J, Up 25% YTD, Shrugs Off Risperdal Suits YCharts |
| 01:43PM | Jennifer Aniston: Movie Star Turned Hair Care Mogul at CNBC |
| 01:33PM | Midday Glance: Pharmaceuticals companies AP |
| 01:33PM | Midday Glance: Medical Devices companies AP |
| 01:10PM | J&J Phasing Out Metal Hip Replacements and 2 Other Dow Movers to Watch at Wall St. Cheat Sheet |
| 12:05PM | J&J's DePuy to end 2 hip replacement systems AP |
| 11:50AM | Good News For Health Care Stocks Part 2 at Motley Fool |
| 11:30AM | Awareness-Building Efforts Bering Fruit Zacks Small Cap Research |
| 11:30AM | Awareness-Building Efforts Bearing Fruit Zacks Small Cap Research |
| 11:27AM | Midday Movers: DATA, V, ARUN & More at CNBC |
| 10:40AM | Diagnosing Alzheimer's First at Motley Fool |
| 10:26AM | Early Glance: Medical Devices companies AP |
| 10:25AM | Early Glance: Pharmaceuticals companies AP |
| 10:22AM | Small Is Beautiful: Now's the Time for Growth-Oriented Investors to Move Into Small-Cap Stocks Minyanville |
| 09:52AM | Is Johnson & Johnson Still a Good Defensive Play? at Wall St. Cheat Sheet |
| 09:00AM | A Quick Look at Avalon Advisors Big Buys Last Quarter at Motley Fool |
| 07:00AM | Defensive stocks due for a pullback at MarketWatch |
| 04:12AM | These Blue Chips Are Cheaper Than You Think at Seeking Alpha |
| 16-May-13 11:01PM | Final Soccer World Cup Sponsor to Spend $50 Million in 15 Months at Bloomberg |
| 08:34PM | Market Rally A Function Of Liquidity And Speculation at Seeking Alpha |
| 06:55PM | Will Workplace Wellness Screenings Under Obamacare Improve Health? at BusinessWeek |
| 06:46PM | J.&J. Unit Phasing Out All-Metal Hip Devices at New York Times |
| 06:46PM | J.&J. Is Phasing Out Metal Replacement Hips at New York Times |
| 06:32PM | Any Light at the End of the Tunnel for Alzheimer's Disease? at Motley Fool |
| 06:25PM | Is SoCalEd Mired In Crisis Or Controversy? at Forbes |
| 06:13PM | 4 Healthcare Stock Stories For Thursday Investing Wellness at Wall St. Cheat Sheet |
| 06:03PM | Final Glance: Pharmaceuticals companies AP |
| 06:03PM | Final Glance: Medical Devices companies AP |
| 05:40PM | Can Johnson & Johnson Navigate Its Public Relations Tightrope? at Wall St. Cheat Sheet |
| 04:59PM | 13F Watch: Funds Add Healthcare And Trim Technology As Activists Take Center Stage at Seeking Alpha |
| 04:13PM | Why Would I Not Sell Dividend Stocks Even After A 1000% Gain? at Seeking Alpha |
| 04:04PM | J&J Will Stop Sales of Metal-on-Metal Hip Replacements at Bloomberg |
| 03:53PM | What If Long-Term Dividend Investors Buy Before A Crash? at Seeking Alpha |
| 03:46PM | Share Buybacks Vs. Dividends: Which Is More Beneficial? at Seeking Alpha |
| 02:30PM | Building An Income Fortress With Dividends Part II at Motley Fool |
| 01:57PM | Time To Show Optimism For Stocks at Seeking Alpha |
| 01:40PM | What Will $2 Million Get You In Retirement? at Seeking Alpha |
| 01:29PM | Midday Glance: Pharmaceuticals companies AP |
| 01:29PM | Midday Glance: Medical Devices companies AP |
|
|
| Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| CULLEN JAMES | Director | May 07 | Sale | 85.40 | 4,929 | 420,937 | 3,849 | May 08 03:31 PM | | Gorsky Alex | Chairman, CEO | Feb 08 | Option Exercise | 0.00 | 9,981 | 0 | 74,115 | Feb 12 06:27 PM | | Stoffels Paulus | Chief Scientific Officer | Feb 08 | Option Exercise | 0.00 | 18,391 | 0 | 18,490 | Feb 12 06:25 PM | | Ullmann Michael H | VP, General Counsel | Feb 08 | Option Exercise | 0.00 | 8,943 | 0 | 54,706 | Feb 12 06:23 PM | | WELDON WILLIAM C | Former Chairman of the Board | Feb 08 | Option Exercise | 0.00 | 48,906 | 0 | 329,780 | Feb 12 06:19 PM | | Caruso Dominic J | Chief Financial Officer | Feb 08 | Option Exercise | 0.00 | 9,981 | 0 | 57,891 | Feb 12 06:16 PM | | COSGROVE STEPHEN J | Corporate Controller | Feb 08 | Option Exercise | 0.00 | 2,345 | 0 | 85,175 | Feb 22 06:45 PM | | SATCHER DAVID | Director | Feb 05 | Option Exercise | 52.20 | 6,300 | 328,860 | 19,830 | Feb 07 04:54 PM | | Ullmann Michael H | VP, General Counsel | Jan 25 | Option Exercise | 52.20 | 1,915 | 99,963 | 47,115 | Jan 29 04:25 PM | | WELDON WILLIAM C | Director | Dec 13 | Option Exercise | 66.18 | 1,510 | 99,932 | 408,874 | Dec 17 11:21 AM | | LINDQUIST SUSAN L | Director | Dec 07 | Option Exercise | 53.93 | 7,600 | 409,868 | 22,205 | Dec 10 06:10 PM | | LINDQUIST SUSAN L | Director | Dec 07 | Sale | 70.02 | 7,600 | 532,152 | 14,605 | Dec 10 06:10 PM | | CULLEN JAMES | Director | Nov 12 | Option Exercise | 52.20 | 6,300 | 328,860 | 14,704 | Nov 14 11:10 AM | | CULLEN JAMES | Director | Nov 12 | Sale | 69.70 | 13,900 | 968,830 | 8,404 | Nov 14 11:10 AM | | MULLIN LEO F | Director | Oct 23 | Option Exercise | 52.20 | 6,300 | 328,860 | 27,733 | Oct 25 03:02 PM | | Caruso Dominic J | Chief Financial Officer | Oct 19 | Option Exercise | 52.20 | 20,400 | 1,064,880 | 68,258 | Oct 22 04:07 PM | | Caruso Dominic J | Chief Financial Officer | Oct 19 | Sale | 71.95 | 20,400 | 1,467,780 | 47,858 | Oct 22 04:07 PM | | WELDON WILLIAM C | Chairman/CEO | Sep 07 | Option Exercise | 53.93 | 323,150 | 17,427,480 | 730,514 | Sep 11 06:05 PM | | COSGROVE STEPHEN J | Corporate Controller | Sep 07 | Option Exercise | 52.20 | 23,085 | 1,205,037 | 102,915 | Sep 11 06:09 PM | | COSGROVE STEPHEN J | Corporate Controller | Sep 07 | Sale | 67.78 | 20,085 | 1,361,361 | 82,830 | Sep 11 06:09 PM | | WELDON WILLIAM C | Chairman/CEO | Sep 07 | Sale | 67.66 | 323,150 | 21,864,329 | 407,364 | Sep 11 06:05 PM | | COSGROVE STEPHEN J | Corporate Controller | Jul 20 | Option Exercise | 52.20 | 1,915 | 99,963 | 81,267 | Jul 23 01:17 PM | | COLEMAN MARY SUE | Director | Jul 19 | Option Exercise | 53.93 | 7,600 | 409,868 | 21,952 | Jul 20 05:37 PM |
|
|
|
|
|
|
